<DOC>
	<DOCNO>NCT02293447</DOCNO>
	<brief_summary>Uterine artery embolization ( UAE ) minimally invasive treatment woman symptomatic fibroid . It similar hysterectomy term satisfaction symptom improvement , few complication low cost . However , majority woman undergo UFE experience important pain procedure despite optimal analgesia , one third report pain equal bad labor . Pain common cause prolong hospital stay readmission . There need simple , efficient way reduce post-procedural pain . For prospective randomize study , hypothesis anesthetic drug , lidocaine , injected uterine artery diminishes pain post-UFE . Patients randomize 3 group : control , lidocaine inject embolization , lidocaine inject embolization . Pain evaluate use validate scale 4h 24h post-intervention . Hospital length-of-stay total narcotic dose administer evaluated three group . This first Canadian study evaluate lidocaine use pain control UFE patient . Results transferable clinical practice , consider use lidocaine simple cost negligible . It could great impact pain management woman undergo UFE practice setting .</brief_summary>
	<brief_title>Intra-arterial Lidocaine Pain Control Post Uterine Fibroid Embolization</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Anesthetics , Local</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>Indication uterine fibroid embolization : bulk symptom , pain heavy menstrual bleeding attribute fibroid , image confirmation ; Patient must able provide write , informed consent Documented allergy intolerance lidocaine amidetype anesthetic ; Personal familial history malignant familial hyperthermia ; Documented history second third atrioventricular heart block Contraindication uterine fibroid embolization : active infection , suspected malignancy , coagulopathy , pregnancy desire preserve fertility , large pedunculated subserosal fibroid . History previous uterine fibroid embolization .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Uterine</keyword>
	<keyword>Fibroid</keyword>
	<keyword>Embolization</keyword>
	<keyword>Leiomyoma</keyword>
	<keyword>Lidocaine</keyword>
	<keyword>Pain</keyword>
</DOC>